AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma

This year, the 7th edition of the AJCC staging manual has for the first time attributed a unique pTNM staging to intrahepatic cholangiocarcinoma (IHCC) that is intended to replace the 2 Western and ideally also the 2 Eastern systems currently in use. This proposal, which has not yet been validated, was tested in the current study.

[1]  D. Cunningham,et al.  Gemcitabine with or without cisplatin in patients (pts) with advanced or metastatic biliary tract cancer (ABC): Results of a multicenter, randomized phase III trial (the UK ABC-02 trial). , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  G. Launoy,et al.  [Current management and prognosis of intrahepatic cholangiocarcinoma in France]. , 2009, Gastroenterologie clinique et biologique.

[3]  T. Gruenberger,et al.  Lymph node ratio after curative surgery for intrahepatic cholangiocarcinoma , 2009, The British journal of surgery.

[4]  L. Sobin,et al.  A worldwide approach to the TNM staging system: Collaborative efforts of the AJCC and UICC , 2009, Journal of surgical oncology.

[5]  A. Ruzzenente,et al.  Intrahepatic Cholangiocarcinoma: Prognostic Factors After Surgical Resection , 2009, World Journal of Surgery.

[6]  U. Neumann,et al.  Extended Liver Resection for Intrahepatic Cholangiocarcinoma: A Comparison of the Prognostic Accuracy of the Fifth and Sixth Editions of the TNM Classification , 2009, Annals of surgery.

[7]  T. Trarbach,et al.  Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients. , 2009, Journal of the American College of Surgeons.

[8]  G. Launoy,et al.  [Current management and prognosis of intrahepatic cholangiocarcinoma in France]. , 2009, Gastroentérologie Clinique et Biologique.

[9]  M. Monden,et al.  Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases. , 2008, Journal of hepato-biliary-pancreatic surgery.

[10]  I. Endo,et al.  Intrahepatic cholangiocarcinoma , 2014, Radiopaedia.org.

[11]  S. Choi,et al.  What prognostic factors are important for resected intrahepatic cholangiocarcinoma? , 2008, Journal of gastroenterology and hepatology.

[12]  S. Hirohashi,et al.  Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma , 2007, British Journal of Cancer.

[13]  S. Kondo,et al.  Computed tomography evaluation of regional lymph node metastases in patients with biliary cancer , 2007, The British journal of surgery.

[14]  M. Choti,et al.  A Proposed Staging System for Intrahepatic Cholangiocarcinoma , 2008, Annals of Surgical Oncology.

[15]  N. Baxter,et al.  Surgical Management of Intrahepatic Cholangiocarcinoma - A Population-Based Study , 2008, Annals of Surgical Oncology.

[16]  M. Makuuchi,et al.  Report of the 17th Nationwide Follow‐up Survey of Primary Liver Cancer in Japan † , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

[17]  Yoshihiko Maehara,et al.  Proposal of Progression Model for Intrahepatic Cholangiocarcinoma: Clinicopathologic Differences Between Hilar Type and Peripheral Type , 2007, The American journal of surgical pathology.

[18]  Yutaka Matsuyama,et al.  Staging of Hepatocellular Carcinoma: Assessment of the Japanese TNM and AJCC/UICC TNM Systems in a Cohort of 13,772 Patients in Japan , 2007, Annals of surgery.

[19]  E. Hatano,et al.  Implication of Frequent Local Ablation Therapy for Intrahepatic Recurrence in Prolonged Survival of Patients With Hepatocellular Carcinoma Undergoing Hepatic Resection: An Analysis of 610 Patients Over 16 Years Old , 2006, Annals of surgery.

[20]  K. McGlynn,et al.  A Comparison of Trends in the Incidence of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma in the United States , 2006, Cancer Epidemiology Biomarkers & Prevention.

[21]  S. Kubo,et al.  Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma. , 2005, Journal of hepato-biliary-pancreatic surgery.

[22]  S. Todo,et al.  Number of Lymph Node Metastases Is a Significant Prognostic Factor in Intrahepatic Cholangiocarcinoma , 2005, World Journal of Surgery.

[23]  K. McGlynn,et al.  Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? , 2004, Journal of hepatology.

[24]  W. Grigioni,et al.  The Role of Lymphadenectomy for Liver Tumors: Further Considerations on the Appropriateness of Treatment Strategy , 2004, Annals of surgery.

[25]  S. Yamasaki.  Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. , 2003, Journal of hepato-biliary-pancreatic surgery.

[26]  Michael A. Choti,et al.  Trends in Long-Term Survival Following Liver Resection for Hepatic Colorectal Metastases , 2002, Annals of surgery.

[27]  L. Ellis,et al.  Simplified staging for hepatocellular carcinoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  M. Makuuchi,et al.  A new staging system for mass‐forming intrahepatic cholangiocarcinoma , 2001, Cancer.

[29]  L. Aaltonen,et al.  Pathology and genetics of tumours of the digestive system , 2000 .

[30]  S. Kawasaki,et al.  Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. , 2000, Surgery.

[31]  Stanley R. Hamilton,et al.  Pathology and genetics of tumours of the digestive system , 2000 .